Interestingly, SCD1 inhibitors are shown to suppress the formation of tumors that rely on de novo fatty acid synthesis, and are more potent in suppressing cancer cell proliferation compared to ACC or FASN inhibitors [17,18]. This evidence concerns the gene SCD and cancer.